What Sofia Vergara's Case Reveals About IVF's Legal Gray Areas

Couples who create IVF embryos together should consider hiring lawyers before beginning the fertility treatment process, according to reproductive law experts. While unpleasant, much like a prenup, the process can help avoid a messy, complicated legal battle like the “custody” lawsuit against actress Sofia Vergara by her ex-fiancé, Nick Loeb. Few couples take this extra step before attempting IVF. But Vergara and Loeb’s case underscores the need for conscientious couples to prepare for every potential future scenario, no matter how unlikely, said San Diego-based surrogacy lawyer Stephanie Caballero.  Couples already sign consent forms that detail how an IVF lab should distribute embryos in cases of death, divorce and other scenarios, but those forms are an agreement between two parties: the couple and the IVF clinic, not between the partners themselves, explained Caballero, an executive board member of the American Society for Reproductive Medicine’s legal professional group.  Couples who want to guard against any future ambiguity should also hire individual lawyers to hammer out an agreement between themselves, she says. Caballero estimates that hiring lawyers for each partner would add $1,300 to $1,500 to the total cost of IVF, which averages $12,400.   “Would it cost you an extra $1,000 to hire a separate attorney? Yes. One would draft, and the other would review it with [you],” said Caballero, who is...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news

Related Links:

ConclusionsThe onset of a second primary tumour was related with the primary treatment given; thus the risk for those treated with radiotherapy and androgen deprivation therapy more than doubled.ResumenIntroducción y objetivosLa aparición de segundos tumores primarios en pacientes con cáncer de próstata de alto riesgo debe tenerse en cuenta en la evolución natural de la enfermedad. Nuestro objetivo es evaluar la influencia del tratamiento primario con intención curativa de dichos pacientes en el desarrollo de segundos tumores primarios.Material y métodosEstudio retrospectivo...
Source: Actas Urologicas Espanolas - Category: Urology & Nephrology Source Type: research
Publication date: Available online 13 December 2018Source: Actas Urológicas Españolas (English Edition)Author(s): J.M. Cózar, B. Miñana, F. Gómez-Veiga, A. Rodríguez-Antolín, GESCAP GroupAbstractAimsTo describe the 3-year progression-free survival (PFS), overall survival (OS) and disease-specific mortality in the prospective prostate cancer GESCAP cohort, as well as the progression to castration resistance in patients on hormone therapy.Material and methodsProspective, observational, epidemiological, multicentre study. Of the 4087 patients recruited, 3843 were evaluable. The...
Source: Actas Urologicas Espanolas - Category: Urology & Nephrology Source Type: research
ConclusionsThe diagnostic performance of CB in patients with at least one previous negative biopsy was 44%, increasing according to the PI-RADS grade, and low in PI-RADS 3. No clinical variable predictive of cancer was found in patients with PI-RADS 3.ResumenIntroducciónEvaluación de la efectividad de la biopsia cognitiva (BC) en los pacientes con sospecha clínica de cáncer de próstata (caP) y al menos una biopsia negativa (BTR).Material y métodoAnálisis retrospectivo de 144 pacientes con al menos una BTR y una resonancia magnética nuclear (RMN) previa. Los nód...
Source: Actas Urologicas Espanolas - Category: Urology & Nephrology Source Type: research
ConclusionsPatient portals may offer an opportunity to build sustainable programs for decision support and assistance that are integrated with clinic workflows and processes.
Source: American Journal of Preventive Medicine - Category: International Medicine & Public Health Source Type: research
ConclusionA great majority of pregnant women in this study experienced UI. Higher BMI and the presence of other medical conditions are significant risk factors for UI and early screening is required. The need for universal education about UI and pelvic floor muscle exercise is warranted and can potentially prevent postnatal UI and UI later in life.
Source: Journal of Taibah University Medical Sciences - Category: Universities & Medical Training Source Type: research
Claire Daly, 34, of  Coventry, West Midlands, was just days into the three-week break with her husband Matt, 43, in September 2015 when she became fatigued and under the weather.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
This Guest Editorial introduces this month's special Pancreatic Cancer Theme Issue, a series of reviews intended to highlight the pathologic to molecular profiles and diagnoses of benign and neoplastic pancreatic lesions.
Source: American Journal of Pathology - Category: Pathology Authors: Tags: Guest editorial Source Type: research
Pancreatic ductal adenocarcinoma (PDAC) remains a challenging disease that is mostly diagnosed late in the course of the illness. Unlike other cancers in which measurable successes have been achieved with traditional chemotherapy, targeted therapy, and, recently, immunotherapy, PDAC has proved to be poorly responsive to these treatments, with only marginal to modest incremental benefits using conventional cytotoxic therapy. There is, therefore, a great unmet need to develop better therapies based on improved understanding of biology and identification of predictive and prognostic biomarkers that would guide therapy.
Source: American Journal of Pathology - Category: Pathology Authors: Tags: Review Source Type: research
Pancreatic ductal adenocarcinoma (PDAC) has a 5-year survival rate of only 8% and is estimated to be the second leading cause of cancer-related deaths by 2021. Prior convention held that screening for PDAC would not be beneficial; however, a deeper understanding of the carcinogenesis pathway supports a potential window of opportunity among the target population. Screening for PDAC is not a standard practice among the general population because of its low incidence. However, screening may be beneficial for individuals with familial history, chronic diseases with genetic predispositions, or inherited cancer syndromes, such a...
Source: American Journal of Pathology - Category: Pathology Authors: Tags: Review Source Type: research
Pancreatic ductal adenocarcinoma (PDAC), although a rare disease, has a poor prognosis. With 5-year overall survival of 8%, there is a critical need to detect PDAC early or at a premalignant stage. Current screening methods are largely imaging based, but a more focused screening approach based on modifiable and nonmodifiable risk factors may improve the efficacy and likely outcomes of screening. In addition, the pathologic mechanisms that lead to the development of PDAC are discussed in an effort to further understand the targets of pancreatic cancer screening.
Source: American Journal of Pathology - Category: Pathology Authors: Tags: Review Source Type: research
More News: Babies | Breast Cancer | Cancer | Cancer & Oncology | Cancer of the Uterus | Chemotherapy | Children | Contracts | Genetics | Infertility | Lawsuits | Legislation | Lymphoma | Medical Law | Oral Cancer | Pregnancy | Pregnancy and Breast Cancer | Reproduction Medicine | Websites | Women